Overview
Founded in Brussels (Anderlecht) in 2014, Fyteko develops biological crop inputs derived from enzymatic processes. Its biostimulant and biopesticide products help farmers reduce dependence on synthetic chemicals while maintaining or improving crop yields. The company targets the regulatory and market shift toward integrated pest management and reduced agrochemical use across European agriculture.
Fyteko raised EUR 13M in a Series B round in late 2024, led by Credit Mutuel Impact. The company is commercially active in 8 EU countries, distributing through agricultural retailers and agronomy networks.
The company operates in the same Belgian biotech cluster as Animab, and benefits from Belgium's strong tradition of applied life sciences research.
Funding & milestones
1 events found for Fyteko · 2025
Series BVenture / equityDetailsEUR 13M
Reported amount EUR 13,000,000
Source not attached to this recordDeal record
Recorded history so far. Original currencies are preserved; amounts in different currencies are not added together. Debt, grants, acquisitions and listings are separate event types. Undated events appear last.
Profile narrative
- Series B, EUR 13M, late 2024: Credit Mutuel Impact (lead)
Key people
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.